Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.735
-0.085 (-4.67%)
Oct 10, 2025, 12:12 PM EDT - Market open
Coherus Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Cash & Equivalents | 216.89 | 125.99 | 102.89 | 63.55 | 417.2 | 541.16 | Upgrade |
Short-Term Investments | 20.74 | - | 14.86 | 128.13 | - | - | Upgrade |
Cash & Short-Term Investments | 237.64 | 125.99 | 117.75 | 191.68 | 417.2 | 541.16 | Upgrade |
Cash Growth | 49.23% | 7.00% | -38.57% | -54.05% | -22.91% | 204.59% | Upgrade |
Accounts Receivable | 5.11 | 111.32 | 260.52 | 109.96 | 123.02 | 157.05 | Upgrade |
Other Receivables | 114.53 | 11.01 | - | - | - | - | Upgrade |
Total Trade Receivables | 119.64 | 122.33 | 260.52 | 109.96 | 123.02 | 157.05 | Upgrade |
Inventory | 4.51 | 4.21 | 62.61 | 38.79 | 37.64 | 44.23 | Upgrade |
Other Current Assets | 18.42 | 89.06 | 34.76 | 40.8 | 24.46 | 25.04 | Upgrade |
Total Current Assets | 380.21 | 341.58 | 475.63 | 381.23 | 602.32 | 767.48 | Upgrade |
Net Property, Plant & Equipment | 1.91 | 2.58 | 5.12 | 8.75 | 7.81 | 10.11 | Upgrade |
Other Intangible Assets | 52.31 | 53.65 | 71.67 | 5.93 | 3.56 | 2.62 | Upgrade |
Goodwill | - | - | - | - | - | 0.94 | Upgrade |
Other Long-Term Assets | 5.04 | 50.73 | 77.18 | 84.93 | 65.64 | 60.5 | Upgrade |
Total Assets | 439.46 | 448.53 | 629.6 | 480.85 | 679.33 | 841.65 | Upgrade |
Accounts Payable | 37.62 | 28.46 | 35.22 | 11.53 | 16.16 | 15.2 | Upgrade |
Accrued Expenses | 226.01 | 254.53 | 296.55 | 127.17 | 149.17 | 130.45 | Upgrade |
Total Current Liabilities | 263.63 | 282.98 | 331.77 | 138.69 | 165.33 | 145.65 | Upgrade |
Long-Term Debt | 36.87 | 264.93 | 473.37 | 471.06 | 408.28 | 404.02 | Upgrade |
Long-Term Leases | 2.41 | 2.29 | 5.33 | 5.05 | 7.25 | 9.95 | Upgrade |
Other Long-Term Liabilities | 16.74 | 29.33 | 12.56 | 3.47 | 0.75 | 1.05 | Upgrade |
Total Long-Term Liabilities | 56.01 | 296.54 | 491.26 | 479.57 | 416.28 | 415.02 | Upgrade |
Total Liabilities | 319.64 | 580.52 | 823.03 | 618.27 | 581.61 | 560.68 | Upgrade |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade |
Additional Paid-in Capital | 1,430 | 1,419 | 1,386 | 1,204 | 1,148 | 1,044 | Upgrade |
Accumulated Other Comprehensive Income | -0.28 | -0.28 | -0.25 | -0.25 | -0.27 | -0.27 | Upgrade |
Retained Earnings | -1,310 | -1,551 | -1,580 | -1,342 | -1,050 | -762.75 | Upgrade |
Shareholders' Equity | 119.83 | -131.99 | -193.43 | -137.42 | 97.73 | 280.97 | Upgrade |
Total Liabilities & Equity | 439.46 | 448.53 | 629.6 | 480.85 | 679.33 | 841.65 | Upgrade |
Total Debt | 39.27 | 267.21 | 478.7 | 476.1 | 415.53 | 413.97 | Upgrade |
Net Cash (Debt) | 198.36 | -141.23 | -360.95 | -284.42 | 1.66 | 127.19 | Upgrade |
Net Cash Growth | - | - | - | - | -98.69% | - | Upgrade |
Net Cash Per Share | 1.86 | -1.23 | -3.83 | -3.66 | 0.02 | 1.52 | Upgrade |
Book Value | 119.83 | -131.99 | -193.43 | -137.42 | 97.73 | 280.97 | Upgrade |
Book Value Per Share | 1.12 | -1.15 | -2.05 | -1.77 | 1.30 | 3.37 | Upgrade |
Tangible Book Value | 67.52 | -185.64 | -265.1 | -143.35 | 94.16 | 277.41 | Upgrade |
Tangible Book Value Per Share | 0.63 | -1.62 | -2.82 | -1.85 | 1.25 | 3.32 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.